Literature DB >> 16321984

Active site distortion is sufficient for proteinase inhibition by serpins: structure of the covalent complex of alpha1-proteinase inhibitor with porcine pancreatic elastase.

Alexey Dementiev1, József Dobó, Peter G W Gettins.   

Abstract

We report here the x-ray structure of a covalent serpin-proteinase complex, alpha1-proteinase inhibitor (alpha1PI) with porcine pancreatic elastase (PPE), which differs from the only other x-ray structure of such a complex, that of alpha1PI with trypsin, in showing nearly complete definition of the proteinase. alpha1PI complexes with trypsin, PPE, and human neutrophil elastase (HNE) showed similar rates of deacylation and enhanced susceptibility to proteolysis by exogenous proteinases in solution. The differences between the two x-ray structures therefore cannot arise from intrinsic differences in the inhibition mechanism. However, self-proteolysis of purified complex resulted in rapid cleavage of the trypsin complex, slower cleavage of the PPE complex, and only minimal cleavage of the HNE complex. This suggests that the earlier alpha1 PI-trypsin complex may have been proteolyzed and that the present structure is more likely to be representative of serpin-proteinase complexes. The present structure shows that active site distortion alone is sufficient for inhibition and suggests that enhanced proteolysis is not necessarily exploited in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16321984     DOI: 10.1074/jbc.M510564200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Determining serpin conformational distributions with single molecule fluorescence.

Authors:  Nicole Mushero; Anne Gershenson
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

2.  How the serpin α1-proteinase inhibitor folds.

Authors:  Klavs Dolmer; Peter G W Gettins
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

3.  SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition.

Authors:  J Cooley; M K Sontag; F J Accurso; E Remold-O'Donnell
Journal:  Eur Respir J       Date:  2010-09-03       Impact factor: 16.671

Review 4.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

5.  Paucimannose-Rich N-glycosylation of Spatiotemporally Regulated Human Neutrophil Elastase Modulates Its Immune Functions.

Authors:  Ian Loke; Ole Østergaard; Niels H H Heegaard; Nicolle H Packer; Morten Thaysen-Andersen
Journal:  Mol Cell Proteomics       Date:  2017-06-19       Impact factor: 5.911

6.  The Spn4 gene from Drosophila melanogaster is a multipurpose defence tool directed against proteases from three different peptidase families.

Authors:  Mareke Brüning; Martina Lummer; Caterina Bentele; Marcel M W Smolenaars; Kees W Rodenburg; Hermann Ragg
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

7.  Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition.

Authors:  Lawrence C Thompson; Sumit Goswami; David S Ginsberg; Duane E Day; Ingrid M Verhamme; Cynthia B Peterson
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

8.  Short-lived protease serpin complexes: partial disruption of the rat trypsin active site.

Authors:  Lu Liu; Nicole Mushero; Lizbeth Hedstrom; Anne Gershenson
Journal:  Protein Sci       Date:  2007-11       Impact factor: 6.725

9.  Engineering D-helix of antithrombin in alpha-1-proteinase inhibitor confers antiinflammatory properties on the chimeric serpin.

Authors:  L Yang; P Dinarvand; S H Qureshi; A R Rezaie
Journal:  Thromb Haemost       Date:  2014-02-13       Impact factor: 5.249

10.  Kinetic intermediates en route to the final serpin-protease complex: studies of complexes of α1-protease inhibitor with trypsin.

Authors:  Ashoka A Maddur; Richard Swanson; Gonzalo Izaguirre; Peter G W Gettins; Steven T Olson
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.